002082 万邦德
已收盘 10-18 15:00:00
资讯
新帖
简况
10月18日万邦德涨停分析:医疗器械,骨科材料,新冠疫苗概念热股
证券之星 · 10-18 15:36
10月18日万邦德涨停分析:医疗器械,骨科材料,新冠疫苗概念热股
异动快报:万邦德(002082)10月18日10点47分触及涨停板
证券之星 · 10-18 10:50
异动快报:万邦德(002082)10月18日10点47分触及涨停板
万邦德:关于董事兼财务总监辞职的公告
新浪财经-鹰眼工作室 · 09-29
万邦德:关于董事兼财务总监辞职的公告
万邦德(002082)9月3日主力资金净买入40.42万元
证券之星 · 09-03
万邦德(002082)9月3日主力资金净买入40.42万元
图解万邦德中报:第二季度单季净利润同比增108.49%
证券之星 · 08-29
图解万邦德中报:第二季度单季净利润同比增108.49%
万邦德(002082.SZ)发布上半年业绩,净利润3770.41万元,增长19.36%
智通财经 · 08-28
万邦德(002082.SZ)发布上半年业绩,净利润3770.41万元,增长19.36%
万邦德(002082)8月13日主力资金净卖出149.97万元
证券之星 · 08-13
万邦德(002082)8月13日主力资金净卖出149.97万元
万邦德最新公告:子公司康慈医疗签订5390.72万元国有土地上房屋收购补偿协议书
证券之星 · 08-12
万邦德最新公告:子公司康慈医疗签订5390.72万元国有土地上房屋收购补偿协议书
万邦德:感谢您的指正,由于排版过程的失误给投资者造成了不好的阅读体验,深表歉意
证券之星 · 07-31
万邦德:感谢您的指正,由于排版过程的失误给投资者造成了不好的阅读体验,深表歉意
万邦德(002082)7月18日主力资金净买入39.87万元
证券之星 · 07-18
万邦德(002082)7月18日主力资金净买入39.87万元
万邦德(002082)7月17日主力资金净买入327.26万元
证券之星 · 07-17
万邦德(002082)7月17日主力资金净买入327.26万元
万邦德(002082)7月9日主力资金净买入59.64万元
证券之星 · 07-09
万邦德(002082)7月9日主力资金净买入59.64万元
【万邦德(002082.SZ)2023年度权益分派:每10股派0.8元】智通财经APP讯,万邦德(002082.SZ)发布公告,公司2023年年度权益分派方案为:以公司现有总股本剔除已回购股份后为基数,向全体股东每10股派0.
智通财经 · 07-04
【万邦德(002082.SZ)2023年度权益分派:每10股派0.8元】智通财经APP讯,万邦德(002082.SZ)发布公告,公司2023年年度权益分派方案为:以公司现有总股本剔除已回购股份后为基数,向全体股东每10股派0.
万邦德(002082.SZ)2023年度权益分派:每10股派0.8元
智通财经 · 07-04
万邦德(002082.SZ)2023年度权益分派:每10股派0.8元
万邦德最新公告:2023年度权益分派10派0.8元 股权登记日7月10日
证券之星 · 07-04
万邦德最新公告:2023年度权益分派10派0.8元 股权登记日7月10日
【万邦德(002082.SZ):石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定】智通财经APP讯,万邦德(002082.
智通财经 · 05-29
【万邦德(002082.SZ):石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定】智通财经APP讯,万邦德(002082.
万邦德(002082.SZ):石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定
智通财经 · 05-29
万邦德(002082.SZ):石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定
万邦德:子公司产品石杉碱甲获得美国FDA孤儿药认定。
华尔街见闻 · 05-29
万邦德:子公司产品石杉碱甲获得美国FDA孤儿药认定。
万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股
智通财经 · 05-24
万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股
【万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股】智通财经APP讯,万邦德(002082.
智通财经 · 05-24
【万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股】智通财经APP讯,万邦德(002082.
公司概况
公司名称:
万邦德医药控股集团股份有限公司
所属行业:
医药制造业
上市日期:
2006-11-20
主营业务:
万邦德医药控股集团股份有限公司主营业务为现代中药、化学原料药及化学制剂的研发、生产和销售以及提供高端医疗器械研制、医疗设备服务和提供医院工程服务。主要产品是心脑血管系统主导产品、神经系统主导产品、呼吸系统主导产品、消化系统主导产品、精神系统主导产品、骨科植入器械、医疗设备及医院工程服务、一次性无菌医用高分子耗材、防护用品。
发行价格:
6.36
{"stockData":{"symbol":"002082","market":"SZ","secType":"STK","nameCN":"万邦德","latestPrice":5.04,"timestamp":1729234995000,"preClose":4.58,"halted":0,"volume":10737620,"delay":0,"floatShares":617000000,"shares":617000000,"eps":0.0898,"marketStatus":"已收盘","marketStatusCode":5,"change":0.46,"latestTime":"10-18 15:00:00","open":4.59,"high":5.04,"low":4.56,"amount":52124800,"amplitude":0.1048,"askPrice":0,"askSize":0,"bidPrice":5.04,"bidSize":76909,"shortable":0,"etf":0,"ttmEps":0.0898,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1729474200000},"adr":0,"adjPreClose":4.58,"symbolType":"stock","openAndCloseTimeList":[[1729215000000,1729222200000],[1729227600000,1729234800000]],"highLimit":5.04,"lowLimit":4.12,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":616689055,"pbRate":1.05,"roa":"--","roe":"1.41%","epsLYR":0.08,"marketValue":3108000000,"floatMarketCap":3108000000,"peRate":56.124721,"changeRate":0.1004,"turnoverRate":0.0174,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-10-21。"},"requestUrl":"/m/hq/s/002082/wiki","defaultTab":"wiki","newsList":[{"id":"2476761424","title":"10月18日万邦德涨停分析:医疗器械,骨科材料,新冠疫苗概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476761424","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476761424?lang=zh_cn&edition=full","pubTime":"2024-10-18 15:36","pubTimestamp":1729236970,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦德10月18日涨停收盘,收盘价5.04元。该股于10点47分涨停,未打开涨停,截止收盘封单资金为3876.25万元,占其流通市值1.25%。10月18日的资金流向数据方面,主力资金净流入2357.34万元,占总成交额45.23%,游资资金净流出1164.07万元,占总成交额22.33%,散户资金净流出1193.27万元,占总成交额22.89%。近5日资金流向一览见下表:该股为医疗器械,骨科材料,新冠疫苗概念热股,当日医疗器械概念上涨3.87%,骨科材料概念上涨3.8%,新冠疫苗概念上涨3.49%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800020782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002082","BK0050","159646","BK1574","09997","BK1100","BK0239","BK0004","BK0028","09996","159883","BK1583","BK1222"],"gpt_icon":0},{"id":"2476196504","title":"异动快报:万邦德(002082)10月18日10点47分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2476196504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476196504?lang=zh_cn&edition=full","pubTime":"2024-10-18 10:50","pubTimestamp":1729219823,"startTime":"0","endTime":"0","summary":"证券之星10月18日盘中消息,10点47分万邦德触及涨停板。目前价格5.04,上涨10.04%。该股为新冠疫苗,阿尔茨海默病,新冠药物概念热股,当日新冠疫苗概念上涨1.63%,阿尔茨海默病概念上涨1.56%,新冠药物概念上涨1.54%。近5日资金流向一览见下表:万邦德主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800012637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0239","BK0050","BK0028","002082"],"gpt_icon":0},{"id":"2471834782","title":"万邦德:关于董事兼财务总监辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2471834782","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471834782?lang=zh_cn&edition=full","pubTime":"2024-09-29 19:00","pubTimestamp":1727607600,"startTime":"0","endTime":"0","summary":"万邦德医药控股集团股份有限公司关于董事兼财务总监辞职的公告本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。万邦德医药控股集团股份有限公司董事会于近日收到公司董事兼财务总监王天放先生的书面辞职报告。王天放先生由于个人原因提请辞去公司第九届董事会董事、财务总监职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-09-29/doc-incqvnxq5823073.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-09-29/doc-incqvnxq5823073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0028","BK0050","BK0004","002082"],"gpt_icon":0},{"id":"2464284758","title":"万邦德(002082)9月3日主力资金净买入40.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2464284758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464284758?lang=zh_cn&edition=full","pubTime":"2024-09-03 15:22","pubTimestamp":1725348140,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月3日收盘,万邦德报收于4.24元,下跌1.17%,换手率0.74%,成交量4.54万手,成交额1940.38万元。9月3日的资金流向数据方面,主力资金净流入40.42万元,占总成交额2.08%,游资资金净流入105.41万元,占总成交额5.43%,散户资金净流出145.83万元,占总成交额7.52%。万邦德主营业务:医药制造、医疗器械大健康产业。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300019084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002082","BK0050","BK0239","BK0028","BK0004"],"gpt_icon":0},{"id":"2463975274","title":"图解万邦德中报:第二季度单季净利润同比增108.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463975274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463975274?lang=zh_cn&edition=full","pubTime":"2024-08-29 02:01","pubTimestamp":1724868089,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦德2024年中报显示,公司主营收入7.53亿元,同比上升1.93%;归母净利润3770.41万元,同比上升19.36%;扣非净利润1807.29万元,同比下降4.53%;其中2024年第二季度,公司单季度主营收入3.24亿元,同比下降8.41%;单季度归母净利润886.56万元,同比上升108.49%;单季度扣非净利润397.56万元,同比上升167.58%;负债率35.4%,投资收益22.86万元,财务费用1382.47万元,毛利率37.33%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900002492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002082"],"gpt_icon":0},{"id":"2462649574","title":"万邦德(002082.SZ)发布上半年业绩,净利润3770.41万元,增长19.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462649574","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462649574?lang=zh_cn&edition=full","pubTime":"2024-08-28 22:35","pubTimestamp":1724855728,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万邦德(002082.SZ)发布2024年半年度报告,报告期内,公司实现营业收入7.53亿元,同比增长1.93%。实现归属于上市公司股东的净利润3770.41万元,同比增长19.36%。实现归属于上市公司股东的扣除非经常性损益的净利润1807.29万元,同比下降4.53%。基本每股收益0.0611元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1174046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002082"],"gpt_icon":0},{"id":"2459294299","title":"万邦德(002082)8月13日主力资金净卖出149.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459294299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459294299?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:24","pubTimestamp":1723533892,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月13日收盘,万邦德报收于4.52元,下跌1.53%,换手率1.42%,成交量8.78万手,成交额3939.69万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:万邦德2024年一季报显示,公司主营收入4.29亿元,同比上升11.41%;归母净利润2883.85万元,同比上升5.49%;扣非净利润1409.73万元,同比下降43.19%;负债率36.73%,投资收益22.86万元,财务费用1115.1万元,毛利率36.17%。万邦德主营业务:医药制造、医疗器械大健康产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0004","002082","BK0239","BK0050"],"gpt_icon":0},{"id":"2458893549","title":"万邦德最新公告:子公司康慈医疗签订5390.72万元国有土地上房屋收购补偿协议书","url":"https://stock-news.laohu8.com/highlight/detail?id=2458893549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458893549?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:01","pubTimestamp":1723471276,"startTime":"0","endTime":"0","summary":"万邦德公告,子公司康慈医疗拟与山海建设签订《国有土地上房屋收购补偿协议书》,因江山市江贺经济走廊土地有机更新和整治提升需要,康慈医疗位于江山市江山经济开发区山海协作区汇源路20号的土地、建筑及附属物、设施设备等被征收,共计可获得补偿奖励款为人民币5390.72万元,补偿方式为货币补偿。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200032843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159891","BK0028","BK0050","BK0004","002082"],"gpt_icon":0},{"id":"2455989188","title":"万邦德:感谢您的指正,由于排版过程的失误给投资者造成了不好的阅读体验,深表歉意","url":"https://stock-news.laohu8.com/highlight/detail?id=2455989188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455989188?lang=zh_cn&edition=full","pubTime":"2024-07-31 18:00","pubTimestamp":1722420057,"startTime":"0","endTime":"0","summary":"感谢您的指正,由于排版过程的失误给投资者造成了不好的阅读体验,深表歉意。为提高投资者对定期报告的阅读体验,公司将不断优化排版格式及图表呈现,同时进一步加强信息披露文件的细节把控。公司致力于为全球患者带来更好的临床获益,美国FDA的孤儿药以及罕见儿科疾病相关认定,为产品的国际化开发奠定了良好的法规注册基础。目前FDA新药物申请正常推进中,尚未开始临床试验环节。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100038470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0028","BK0050","002082","BK0239"],"gpt_icon":0},{"id":"2452752511","title":"万邦德(002082)7月18日主力资金净买入39.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452752511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452752511?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:27","pubTimestamp":1721287632,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月18日收盘,万邦德报收于4.15元,下跌2.35%,换手率1.39%,成交量8.59万手,成交额3544.89万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:万邦德2024年一季报显示,公司主营收入4.29亿元,同比上升11.41%;归母净利润2883.85万元,同比上升5.49%;扣非净利润1409.73万元,同比下降43.19%;负债率36.73%,投资收益22.86万元,财务费用1115.1万元,毛利率36.17%。万邦德主营业务:医药制造、医疗器械大健康产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800027263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0050","002082","BK0004","BK0239","BK0028"],"gpt_icon":0},{"id":"2452918610","title":"万邦德(002082)7月17日主力资金净买入327.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452918610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452918610?lang=zh_cn&edition=full","pubTime":"2024-07-17 15:21","pubTimestamp":1721200895,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月17日收盘,万邦德报收于4.25元,上涨2.66%,换手率0.99%,成交量6.13万手,成交额2583.29万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:万邦德2024年一季报显示,公司主营收入4.29亿元,同比上升11.41%;归母净利润2883.85万元,同比上升5.49%;扣非净利润1409.73万元,同比下降43.19%;负债率36.73%,投资收益22.86万元,财务费用1115.1万元,毛利率36.17%。万邦德主营业务:医药制造、医疗器械大健康产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700026494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0004","002082","BK0028","BK0050"],"gpt_icon":0},{"id":"2450846096","title":"万邦德(002082)7月9日主力资金净买入59.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450846096","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450846096?lang=zh_cn&edition=full","pubTime":"2024-07-09 15:26","pubTimestamp":1720509981,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月9日收盘,万邦德报收于4.13元,下跌0.96%,换手率0.77%,成交量4.73万手,成交额1944.96万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:万邦德2024年一季报显示,公司主营收入4.29亿元,同比上升11.41%;归母净利润2883.85万元,同比上升5.49%;扣非净利润1409.73万元,同比下降43.19%;负债率36.73%,投资收益22.86万元,财务费用1115.1万元,毛利率36.17%。万邦德主营业务:医药制造、医疗器械大健康产业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900027055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0050","BK0004","002082","BK0028"],"gpt_icon":0},{"id":"2448940448","title":"【万邦德(002082.SZ)2023年度权益分派:每10股派0.8元】智通财经APP讯,万邦德(002082.SZ)发布公告,公司2023年年度权益分派方案为:以公司现有总股本剔除已回购股份后为基数,向全体股东每10股派0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448940448","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448940448?lang=zh_cn&edition=full","pubTime":"2024-07-04 17:47","pubTimestamp":1720086452,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0004","BK0239","BK0050","BK0028","002082"],"gpt_icon":0},{"id":"2448448149","title":"万邦德(002082.SZ)2023年度权益分派:每10股派0.8元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448448149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448448149?lang=zh_cn&edition=full","pubTime":"2024-07-04 17:47","pubTimestamp":1720086452,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万邦德(002082.SZ)发布公告,公司2023年年度权益分派方案为:以公司现有总股本剔除已回购股份后为基数,向全体股东每10股派0.8元人民币现金(含税),本次权益分派股权登记日为:2024年7月10日,除权除息日为:2024年7月11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0004","002082","BK0239","BK0050"],"gpt_icon":0},{"id":"2448448169","title":"万邦德最新公告:2023年度权益分派10派0.8元 股权登记日7月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2448448169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448448169?lang=zh_cn&edition=full","pubTime":"2024-07-04 17:39","pubTimestamp":1720085989,"startTime":"0","endTime":"0","summary":"万邦德公布2023年年度权益分派实施公告,公司2023年年度权益分派方案为:以公司现有总股本剔除已回购股份5,000,000股后的611,689,055股为基数,向全体股东每10股派0.8元人民币现金(含税)。本次权益分派股权登记日为:2024年7月10日,除权除息日为:2024年7月11日。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400034980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002082","BK0004","BK0239","BK0028","BK0050"],"gpt_icon":0},{"id":"2439546716","title":"【万邦德(002082.SZ):石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定】智通财经APP讯,万邦德(002082.","url":"https://stock-news.laohu8.com/highlight/detail?id=2439546716","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439546716?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:17","pubTimestamp":1716977851,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HIE","BK0004","01477","BK0239","BK1191","BK0050","BK1574","BK0028","002082"],"gpt_icon":0},{"id":"2439462415","title":"万邦德(002082.SZ):石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2439462415","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439462415?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:17","pubTimestamp":1716977851,"startTime":"0","endTime":"0","summary":"本次石杉碱甲治疗新生儿缺氧缺血性脑病适应症获得FDA孤儿药资格认定,是继石杉碱甲用于重症肌无力获得FDA孤儿药资格认定,及治疗新生儿缺氧缺血性脑病适应症获得FDA“罕见儿科疾病”药物资格认定后的又一重要进展,本次认定将有助于加快公司药品国际化战略布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1127780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0004","BK0239","BK0050","BK0028","002082"],"gpt_icon":0},{"id":"2439654684","title":"万邦德:子公司产品石杉碱甲获得美国FDA孤儿药认定。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439654684","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439654684?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:10","pubTimestamp":1716977421,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["002082","BK0050","BK0239","BK0004","BK0028"],"gpt_icon":0},{"id":"2437808930","title":"万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2437808930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437808930?lang=zh_cn&edition=full","pubTime":"2024-05-24 19:06","pubTimestamp":1716548767,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万邦德(002082.SZ)公告,公司实际控制人之一、董事长、总经理赵守明增持股份计划实施完毕,其累计增持公司股份732.69万股,占公司现有总股本的1.1881%,增持金额为3277.98万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1125946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0050","002082","BK0004","BK0239","BK0028"],"gpt_icon":0},{"id":"2437708088","title":"【万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股】智通财经APP讯,万邦德(002082.","url":"https://stock-news.laohu8.com/highlight/detail?id=2437708088","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437708088?lang=zh_cn&edition=full","pubTime":"2024-05-24 19:06","pubTimestamp":1716548767,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0004","002082","BK0239","BK0028","BK0050"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2006-11-20","address":"浙江省湖州市吴兴区织里镇栋梁路1688号","stockEarnings":[{"period":"1week","weight":0.0957},{"period":"1month","weight":0.2727},{"period":"3month","weight":0.2086},{"period":"6month","weight":0.2095},{"period":"1year","weight":-0.2258},{"period":"ytd","weight":-0.1968}],"companyName":"万邦德医药控股集团股份有限公司","boardCode":"AI0027","perCapita":"184600股","boardName":"医药制造业","registeredCapital":"61668万元","compareEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.2003},{"period":"3month","weight":0.0936},{"period":"6month","weight":0.064},{"period":"1year","weight":0.0852},{"period":"ytd","weight":0.0963}],"survey":" 万邦德医药控股集团股份有限公司主营业务为现代中药、化学原料药及化学制剂的研发、生产和销售以及提供高端医疗器械研制、医疗设备服务和提供医院工程服务。主要产品是心脑血管系统主导产品、神经系统主导产品、呼吸系统主导产品、消化系统主导产品、精神系统主导产品、骨科植入器械、医疗设备及医院工程服务、一次性无菌医用高分子耗材、防护用品。","serverTime":1729305663046,"listedPrice":6.36,"stockholders":"29957人(较上一季度减少82.75%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦德(002082)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦德,002082,万邦德股票,万邦德股票老虎,万邦德股票老虎国际,万邦德行情,万邦德股票行情,万邦德股价,万邦德股市,万邦德股票价格,万邦德股票交易,万邦德股票购买,万邦德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦德(002082)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}